| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 861,039 | 1,158,209 | 1,774,138 | 1,906,840 | | Cost of Revenue | 282,081 | 284,698 | 476,377 | 280,270 | | | Gross Profit | 578,958 | 873,511 | 1,297,761 | 1,626,570 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 156,302 | 137,299 | 99,179 | 168,664 | | Non Recurring | 47,046 | 65,471 | 79,268 | 32,142 | | Others | 375,592 | 389,329 | 368,135 | (966,419) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18 | 281,412 | 751,179 | 2,392,183 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,237 | 1,739 | 2,256 | 13,864 | | Earnings Before Interest And Taxes | 1,255 | 283,151 | 753,435 | 2,406,047 | | Interest Expense | 24,811 | 18,376 | 18,343 | 12,095 | | Income Before Tax | (23,556) | 264,775 | 735,092 | 2,393,952 | | Income Tax Expense | (6,850) | 106,065 | 273,620 | 837,667 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (16,706) | 158,710 | 461,472 | 1,556,285 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (16,706) | 158,710 | 461,472 | 1,556,285 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,706) | $158,710 | $461,472 | $1,556,285 |
|
0.27% Nasdaq 
0.26 (0.28%) 
Income Statement
